𝔖 Bobbio Scriptorium

✦ LIBER ✦

The genetic defect of type i von willebrand disease “vicenza” is linked to the von willebrand factor gene: E.Sacchi∗, A.M.Randi∗, G.C.Castaman+, F.Rodeghiero+, P.M.Mannucci∗.∗ A.Bianchi Bonomi Hemophilia and Thrombosis Center, IRCCS Ospedale Maggiore, University of Milan; + Hemophilia and Thrombosis Center and Department of Hematology, Vicenza, Italy

Book ID: 116086544
Publisher: Elsevier Science
Year: 1993
Tongue: English
Weight: 103 KB
Volume: 70
Category: Article
ISSN: 0049-3848
DOI: 10.1016/0049-3848(93)90443-r

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Apparent autosomal recessive inheritance

Apparent autosomal recessive inheritance in patients with type II a von Willebrand disease: N. Ciavarella, G. C. Castaman, M. Schiavoni, G. Ciavarella, F. Rodeghiero, P.M. Mannucci, A.B. Federici. A. Bianchi Bonomi Hemophilia and Thrombosis Center, University of Milan - Hemophilia Center of Bari - Department of Hematology of Vicenza

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 86 KB

Uremic patients have normal plasma and p

Uremic patients have normal plasma and platelet von willebrand factor structure, regardless of bleeding time: G.Castaman, F.Rodeghiero, A.Lattuada, P. Conz, G. La Greca, P.M.Mannucci. Department of Hematology and Hemophilia and Thrombosis Center and Department of Nephrology, San Bortolo Hospital, Vicenza; “A. Bianchi Bonomi” Hemophilia and Thrombosis Center, University of Milano

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 95 KB

Studies of vWF-botrocetin complex in pat

Studies of vWF-botrocetin complex in patients with different subtypes of type ii von willebrand disease: F.I.Pareti, R.Coppola, C. Bressi, A.B. Federici, P.M. Mannucci. Hemophilia and Thrombosis Center, A. Bianchi Bonomi IRCCS Maggiore Hospital and University, Milan, Italy

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 103 KB

Type I “platelet low” von willebrand dis

Type I “platelet low” von willebrand disease: decreased platelet adhesion and low synthesis of von willebrand factor in endothelial cells: A.B. Federici, P.G. de Groot, M. Moia, M.T. Canciani, M. Lucchini, P.M. Mannucci. A. Bianchi Bonomi Hemophilia and Thrombosis Center, IRCCS Maggiore Hospital, University of Milan and University of Utrecht

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 107 KB

Von Willebrand Factor degradation in 20

Von Willebrand Factor degradation in 20 patients with acquired clinical conditions characterized by systemic proteolysis: M.L. Colibretti, S.D. Berkowitz, R, Coppola, R. Lombardi, G. Castaman, P.M. Mannucci, A.B. Federici. A. Bianchi Bonomi Hemophilia and Thrombosis Center, University of Milan and Department of Haematology, Vicenza; Scripps Clinic, La Jolla

📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 88 KB

High dose intravenous immunoglobulins an

High dose intravenous immunoglobulins and DDAVP for the management of a patient with acquired von willebrand disease (AvWD) undergoing hemorrhoidectomy: E. Santagostino, A. Gringeri, M. Cattaneo, M. Ferretti, L. Simoni, P.M. Mannucci. Hemophilia and Thrombosis Center “A. Bianchi Bonomi”, IRCCS Maggiore Hospital and University of Milano, Italy

📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 121 KB